Brown J, Li Z, Wang X, Kim YJ, Wang Y-C, Zuo Y, Hong W, Wang P, Li B*, and Yang L*. (*Co-corresponding authors) Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects. Front Pharmacol. 2022, 13:970324. doi: 10.3389/fphar.2022.970324. [Frontiers in Pharmacology  PDF]